Revance Therapeutics News

Barclays Sticks to Their Buy Rating for Revance Therapeutics (RVNC)

TipRanksApr 23 05:59 ET

OPI, RVNC and AQST Are Among After Hour Movers

Seeking AlphaApr 22 16:53 ET

AbbVie Working With FDA After Reports of Fake Botox Versions

Seeking AlphaApr 16 10:47 ET

Revance To Present New DAXXIFY Data At The American Academy Of Neurology 2024 Annual Meeting

– Two presentations highlighting data on DAXXIFY for the treatment of cervical dystonia, including a new analysis from ASPEN trials assessing patient-desired retreatment intervals and one abstract exa

BenzingaApr 12 08:01 ET

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday.

BenzingaApr 9 10:43 ET

Take Care Before Jumping Onto Revance Therapeutics, Inc. (NASDAQ:RVNC) Even Though It's 35% Cheaper

To the annoyance of some shareholders, Revance Therapeutics, Inc. (NASDAQ:RVNC) shares are down a considerable 35% in the last month, which continues a horrid run for the company. For any long-term

Simply Wall StApr 3 12:03 ET

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revance Therapeutics, Inc. (NASDAQ:RVNC) today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units ("RSUs") to 29 employees. The RSUs vest over four years, with 25% of the

BusinesswireMar 27 16:05 ET

Survey Finds GLP-1 Users More Inclined to Get Aesthetic Procedures

Seeking AlphaMar 17 17:09 ET

Revance Stock Rises After CEO Discloses Share Purchase

Seeking AlphaMar 11 06:37 ET

GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdings Limited (NASDAQ:GDS) shares rose sharply in today's pre-market trading

BenzingaMar 11 05:50 ET

Stocks to Watch: Graphite Bio, Revance Therapeutics

By Sabela Ojea Graphite Bio on Friday said it would pay a special dividend tied to its merger with Lenz Therapeutics. Shares of the biotechnology company climbed 10% to $3.46 in after-hours trading.

WSJMar 8 18:54 ET

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell during Monday's session after the company reportedly saw a decline in Fe

BenzingaMar 4 10:40 ET

Express News | Revance Therapeutics Shares Are Trading Lower After the Company Announced a Proposed Public Offering of $100 Million of Its Common Stock

Moomoo 24/7Mar 4 09:15 ET

Revance Therapeutics Down 7%, Prices $100M Share Offering

Seeking AlphaMar 4 07:39 ET

Express News | Revance Announces Proposed Public Offering Of $100M Common Stock

Moomoo 24/7Mar 4 06:38 ET

Even After Rising 34% This Past Week, Revance Therapeutics (NASDAQ:RVNC) Shareholders Are Still Down 77% Over the Past Year

Revance Therapeutics, Inc. (NASDAQ:RVNC) shareholders will doubtless be very grateful to see the share price up 34% in the last week. But that is meagre solace when you consider how the price has p

Simply Wall StMar 1 07:45 ET

Revance Therapeutics Is Maintained at Neutral by Goldman Sachs

Revance Therapeutics Is Maintained at Neutral by Goldman Sachs

Dow JonesMar 1 06:14 ET

Express News | Goldman Sachs Maintains Neutral on Revance Therapeutics, Raises Price Target to $9

Moomoo 24/7Mar 1 06:04 ET

Earnings Call Summary | Revance Therapeutics(RVNC.US) Q4 2023 Earnings Conference

The following is a summary of the Revance Therapeutics Inc. (RVNC) Q4 2023 Earnings Call Transcript:Financial Performance:Revance Therapeutics reported a 2023 product revenue of $213 million, up 80% y

moomoo AIMar 1 04:46 ET · Conference Call

Express News | HC Wainwright & Co. Reiterates Buy on Revance Therapeutics, Maintains $12 Price Target

Moomoo 24/7Feb 29 15:18 ET